We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
+5.28%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.14B
AUM Growth
+$467M
Cap. Flow
+$273M
Cap. Flow %
5.31%
Top 10 Hldgs %
11.46%
Holding
1,074
New
159
Increased
412
Reduced
333
Closed
136

Top Buys

Rank Stock Value
1
PM icon
Philip Morris
PM
+$28.6M
2
AGN
Allergan plc
AGN
+$26.5M
3
TTC icon
Toro Company
TTC
+$22.4M
4
PEP icon
PepsiCo
PEP
+$20.4M
5
LMT icon
Lockheed Martin
LMT
+$17.5M

Top Sells

Rank Stock Value
1
INTU icon
Intuit
INTU
+$26.1M
2
WFC icon
Wells Fargo
WFC
+$19.4M
3
CNC icon
Centene
CNC
+$17.3M
4
LLY icon
Eli Lilly
LLY
+$15.8M
5
KR icon
Kroger
KR
+$14.8M

Sector Composition

Rank Sector Weight
1 Technology 19.58%
2 Financials 18.08%
3 Industrials 12.96%
4 Healthcare 11.05%
5 Consumer Discretionary 11.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OSG
901
DELISTED
Overseas Shipholding Group Inc.
OSG
$143K ﹤0.01%
+54,248
New +$138K
SYNC
902
DELISTED
Synacor, Inc.
SYNC
$138K ﹤0.01%
50,968
-5,700
-10% -$17.4K
ASPN icon
903
Aspen Aerogels
ASPN
$387M
$137K ﹤0.01%
+31,400
New +$137K
ECOM
904
DELISTED
CHANNELADVISOR CORPORATION
ECOM
$137K ﹤0.01%
+11,890
New +$129K
SUNE
905
SUNation Energy
SUNE
$9.9M
– –
0
– –
LSTA icon
906
Lisata Therapeutics
LSTA
$15.2M
$135K ﹤0.01%
2,512
+986
+65% +$59.9K
SCX
907
DELISTED
The L.S. Starrett Company
SCX
$133K ﹤0.01%
14,916
-656
-4% -$5.23K
INFI
908
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$132K ﹤0.01%
99,527
-254,364
-72% -$316K
STAA icon
909
STAAR Surgical
STAA
$1.16B
$130K ﹤0.01%
+10,470
New +$117K
INSY
910
DELISTED
Insys Therapeutics, Inc.
INSY
$130K ﹤0.01%
+14,640
New +$151K
IVAC
911
DELISTED
Intevac Inc
IVAC
$121K ﹤0.01%
+14,300
New +$139K
SNMX
912
DELISTED
Senomyx, Inc.
SNMX
$116K ﹤0.01%
190,856
+2,300
+1% +$1.59K
CLAR icon
913
Clarus
CLAR
$125M
$113K ﹤0.01%
15,085
-8,845
-37% -$60.7K
TCS
914
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
$109K ﹤0.01%
1,727
-2,314
-57% -$164K
PIR
915
DELISTED
Pier 1 Imports, Inc.
PIR
$109K ﹤0.01%
1,300
-9,806
-88% -$877K
VYNT
916
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
$108K ﹤0.01%
268
– –
WG
917
DELISTED
Willbros Group
WG
$102K ﹤0.01%
+31,703
New +$76.1K
DRRX
918
DELISTED
DURECT Corp
DRRX
$94K ﹤0.01%
+5,299
New +$88.8K
TZOO icon
919
Travelzoo
TZOO
$103M
$91K ﹤0.01%
+10,615
New +$99.1K
TOVX icon
920
Theriva Biologics
TOVX
$10.2M
$90K ﹤0.01%
+11
New +$63.6K
TNTR
921
DELISTED
Tintri, Inc. Common Stock
TNTR
$87K ﹤0.01%
+27,554
New +$159K
LFVN icon
922
LifeVantage
LFVN
$82.4M
$85K ﹤0.01%
20,152
+4,100
+26% +$16.1K
NPTN
923
DELISTED
NEOPHOTONICS CORP
NPTN
$80K ﹤0.01%
+14,300
New +$96.5K
TRVN
924
DELISTED
Trevena, Inc.
TRVN
$78K ﹤0.01%
49
-4
-8% -$6.29K
MRIN
925
DELISTED
Marin Software
MRIN
$66K ﹤0.01%
899
– –
35 36
37
38 39

Similar funds

Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Teacher Retirement System of Texas
Teacher Retirement System of Texas Austin, Texas $24B AUM 29.51% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
CHP
Castle Hook Partners New York $23.4B AUM 158.96% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $23.4B AUM
JG
Jain Global New York $24.2B AUM 34.82% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Jacobs Levy Equity Management's Q3 2017 Portfolio in Review

As of Q3 2017, Jacobs Levy Equity Management held 1,074 positions worth $5.14B, up 10% from $4.68B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Jacobs Levy Equity Management deployed $273M of net new capital in Q3 2017, opening 159 new positions and adding to 412 existing holdings. Its largest new stake was Allergan plc: 114,141 shares worth $23.4M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Intuit, an estimated $26.1M trimmed.

  • Jacobs Levy Equity Management's largest Q3 2017 buy was Allergan plc: 114,141 shares worth $23.4M.
  • Jacobs Levy Equity Management added most to Philip Morris in Q3 2017, an estimated $28.6M increase.
  • Jacobs Levy Equity Management's biggest Q3 2017 reduction was Intuit, cutting an estimated $26.1M.
  • Jacobs Levy Equity Management fully exited BWX Technologies in Q3 2017, selling an estimated $13.7M.
  • Jacobs Levy Equity Management's ten largest holdings make up 11% of its $5.14B portfolio in Q3 2017.
  • Jacobs Levy Equity Management opened 159 new positions and closed 136 in Q3 2017.
  • Jacobs Levy Equity Management's portfolio value rose 10% quarter-over-quarter to $5.14B.

Based on Jacobs Levy Equity Management's 13F filing for Q3 2017, filed 14 Nov 2017.